M&T Bank
IRMD icon

M&T Bank’s iRadimed IRMD Stock Holding History

M&T Bank’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372K Sell
3,896
-2,760
-41% -$251K ﹤0.01% 1355
2026
Q1 		$641K Buy
+6,656
New +$666K ﹤0.01% 1020

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

M&T Bank's IRMD Position: Q2 2026 in Review

M&T Bank reduced its iRadimed (IRMD) stake by 41% in Q2 2026, selling an estimated $251K and leaving 3,896 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #1355.

M&T Bank first reported a position in IRMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $641K in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • M&T Bank held 3,896 shares of iRadimed worth $372K as of Q2 2026.
  • M&T Bank sold 2,760 iRadimed shares in Q2 2026, an estimated $251K.
  • iRadimed made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1355 holding.
  • M&T Bank first reported a position in iRadimed in Q1 2026 and has held it in 2 quarters since.
  • M&T Bank's iRadimed position peaked at $641K in Q1 2026.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.